Postoperative Adjuvant Treatment Strategy for Locally Advanced Rectal Cancer after Neoadjuvant Treatment

Figure 6

Forest plot based on overall survival and tumor stage. (a) OS in chemotherapy group versus observation group in patients with ypStage II; (b) OS in chemotherapy group versus observation group in patients with ypStage III; (c) OS in OX/FU-based group versus FU-based group in patients with ypStage II; (d) OS in OX/FU-based group versus FU-based group in patients with ypStage III; (e) OS in OX/FU-based group versus FU-based group in patients with clinical stage II; (f) OS in OX/FU-based group versus FU-based group in patients with clinical stage III.

(a)

(b)

(c)

(d)

(e)

(f)